Multiple Primary Cancers With Hematologic Malignancies and Germline Predisposition: A Case Series.
Jiwon YunDong Soon LeeSungyoung LeeHongseok YunPublished in: Annals of laboratory medicine (2024)
The term "multiple primary (MP) cancers" refers to the existence of more than one cancer in the same patient. The combination of MP cancers with hematological malignancies is relatively uncommon. In this study, we present five patients diagnosed with MP cancers concomitant with hematological malignancies. We comprehensively analyzed their clinical characteristics, cytogenetic profiles, and germline and somatic variants. As first primaries, two patients had solid cancer not followed by cytotoxic therapy and three had hematologic cancer, followed by cytotoxic therapy. The second primaries were all hematologic malignancies that did not meet the criteria for therapy-related myeloid neoplasm. Notably, two (40%) out of the five patients harbored pathogenic potential/presumed germline variants in cancer predisposition genes. Therefore, germline variant testing should be considered when MP cancers with hematological malignancies require consideration for related donor stem cell transplantation.
Keyphrases
- end stage renal disease
- stem cell transplantation
- papillary thyroid
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- high dose
- childhood cancer
- stem cells
- copy number
- squamous cell
- immune response
- dna methylation
- squamous cell carcinoma
- gene expression
- acute myeloid leukemia
- low dose
- mesenchymal stem cells
- dendritic cells
- genome wide
- bone marrow
- patient reported outcomes